0001104659-24-033963.txt : 20240313 0001104659-24-033963.hdr.sgml : 20240313 20240313163339 ACCESSION NUMBER: 0001104659-24-033963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Steven Clive CENTRAL INDEX KEY: 0001883325 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40825 FILM NUMBER: 24746433 MAIL ADDRESS: STREET 1: C/O WARBY PARKER INC. STREET 2: 233 SPRING STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Warby Parker Inc. CENTRAL INDEX KEY: 0001504776 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 800423634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 847-7215 MAIL ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: JAND, Inc. DATE OF NAME CHANGE: 20101102 4 1 tm248127-7_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-11 0 0001504776 Warby Parker Inc. WRBY 0001883325 Miller Steven Clive C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR EAST NEW YORK NY 10013 0 1 0 0 Chief Financial Officer 1 Class A Common Stock 2024-03-11 4 S 0 24225 11.98 D 166879 D These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2023. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $11.81 to $12.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. /s/ Chris Utecht, Attorney-in-Fact 2024-03-13